Biodesix, Inc. (BDSX)
30.82
+2.74
(+9.78%)
USD |
NASDAQ |
Aug 26, 16:00
30.82
0.00 (0.00%)
After-Hours: 20:00
Biodesix Shareholders Equity (Quarterly) : 9.144M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.144M |
| March 31, 2026 | 9.132M |
| December 31, 2025 | -2.465M |
| September 30, 2025 | -1.722M |
| June 30, 2025 | 1.138M |
| March 31, 2025 | 11.06M |
| December 31, 2024 | 20.88M |
| September 30, 2024 | 27.86M |
| June 30, 2024 | 36.26M |
| March 31, 2024 | -5.502M |
| December 31, 2023 | 4.58M |
| September 30, 2023 | -1.446M |
| June 30, 2023 | -6.993M |
| March 31, 2023 | 4.55M |
| Date | Value |
|---|---|
| December 31, 2022 | 20.61M |
| September 30, 2022 | -2.903M |
| June 30, 2022 | 7.671M |
| March 31, 2022 | 7.781M |
| December 31, 2021 | 19.73M |
| September 30, 2021 | 16.03M |
| June 30, 2021 | 25.77M |
| March 31, 2021 | 36.43M |
| December 31, 2020 | 41.17M |
| September 30, 2020 | -255.18M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -228.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BillionToOne, Inc. | 536.81M |
| Quest Diagnostics, Inc. | 7.516B |
| Labcorp Holdings, Inc. | 8.607B |
| OPKO Health, Inc. | 1.184B |
| Psychemedics Corp. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.33M |
| Total Liabilities (Quarterly) | 86.18M |
| Debt to Equity Ratio | 7.852 |
| Current Ratio | 2.849 |
| Net Debt Paydown Yield | -0.80% |